Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias
BMJ Open Diabetes Res Care (2021) 9(1):e002083
One study was published in 2022, four in 2021, one in 2020 and one in 2018
Patients with SLE have a weakened immune system, which makes them particularly susceptible to infections, a major cause of illness and death among these patients
Our team can help review your benefits and discuss available treatment options
xylitol, erythritol, allulose and other low-calorie sweeteners